You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (92)

Journals (0)

1-10 of 92 results for docetaxel resistance

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Overcoming docetaxel resistance in prostate cancer: a perspective review

Open access

Research article

First published 2012-11

Overcoming docetaxel resistance in prostate cancer: a perspective review

Clara Hwang

Therapeutic Advances in Medical Oncology

Select article: Paclitaxel Administered Weekly in Patients with Docetaxel-Resistant Metastatic Breast Cancer: A Single-Center Study

Retricted access

Other

First published 2004-1

Paclitaxel Administered Weekly in Patients with Docetaxel-Resistant Metastatic Breast Cancer: A Single-Center Study

Masataka Sawaki, Yoshinori Ito, Daigo Hashimoto [...]

Tumori Journal

Select article: LINC00680 modulates docetaxel resistance in breast cancer via the miR-320b/CDKL5 axis

Open access

Research article

First published 2022-05

LINC00680 modulates docetaxel resistance in breast cancer via the miR-320b/CDKL5 axis

Jia Li, Jing Ke, Cheng-lin Qin [...]

International Journal of Immunopathology and Pharmacology

Select article: Post-docetaxel therapy in castration resistant prostate cancer – the forest is growing in the desert

Free access

Research article

First published 2012-6

Post-docetaxel therapy in castration resistant prostate cancer – the forest is growing in the desert

Amelia Altavilla, Roberto Iacovelli, Giuseppe Procopio [...]

Therapeutic Advances in Urology

Select article: Plasma chromogranin A: Clinical implications in patients with castrate resistant prostate cancer receiving docetaxel chemotherapy

Free access

Research article

First published 2010-3

Plasma chromogranin A: Clinical implications in patients with castrate resistant prostate cancer receiving docetaxel chemotherapy

Debansu Sarkar, S.K. Singh, Arup K. Mandal [...]

Cancer Biomarkers

Select article: A castrate-resistant metastatic prostate cancer patient with severe pancytopenia,successfully treated with docetaxel chemotherapy

Retricted access

Case report

First published 2020-7

A castrate-resistant metastatic prostate cancer patient with severe pancytopenia,successfully treated with docetaxel chemotherapy

Anuradha Kunthur

Journal of Oncology Pharmacy Practice

Select article: Evolution of Docetaxel-Based Therapy for Metastatic Castrate-Resistant Prostate Cancer

Retricted access

Review article

First published 2010-11

Evolution of Docetaxel-Based Therapy for Metastatic Castrate-Resistant Prostate Cancer

Philip Cornford

Journal of Clinical Urology

Select article: Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer

Retricted access

Research article

First published 2019-9

Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer

Alisha Shivji, Raafi Ali, Scott North [...]

Journal of Oncology Pharmacy Practice

Select article: Secreted frizzled-related protein 5 suppresses aggressive phenotype and reverses docetaxel resistance in prostate cancer

Retricted access

Research article

First published 2019-8

Secreted frizzled-related protein 5 suppresses aggressive phenotype and reverses docetaxel resistance in prostate cancer

Qiang Xu, Zhong Lü, Xugang Wang [...]

Journal of Investigative Medicine

Select article: GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)

Open access

Research article

First published 2022

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol)

Ciara Conduit, Blossom Mak, Wenjia Qu [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
10
10 / page

Article type

Publication date

Subjects

Access